Biologická role mědi jako základního stopového prvku v lidském organismu

1. Olivares M., Uauy R. Copper as an essential nutrient. Am. J. Clin. Nutr. 1996; 63, 791S–796S.

2. Krupanidhi S., Sreekumar A., Sanjeevi C. B. Copper & biological health. Indian J. Med. Res. 2008; 128, 448–461.

3. Gaetke L. M., Chow-Johnson H. S., Chow Ch. K. Copper: Toxicological relevance and mechanisms. Arch. Toxicol. 2014; 88, 1929–1938.

4. Sharp P. A. Ctr1 and its role in body copper homeostasis. Int. J. Biochem. Cell B. 2003; 35, 288–291.

5. Chillappagari S., Seubert A., Trip H., Kuipers O. P., Marahiel M. A., Miethke M. Copper Stress Affects Iron Homeostasis by Destabilizing Iron-Sulfur Cluster Formation in Bacillus subtilis. J. Bacteriol. 2010; 192, 2512–2524.

6. Ferns G. A. A., Lamb D. J., Taylor A. The possible role of copper ions in atherogenesis: the Blue Janus. Atherosclerosis 1997; 133, 139–152.

7. Arredondo M., Núñez M. T. Iron and copper metabolism. Mol. Aspects Med. 2005; 26, 313–327.

8. Uauy, R., Olivares M., Gonzalez M. Essentiality of copper in humans. Am. J. Clin. Nutr. 1998; 67, 952S–959S.

9. Angelova M., Asenova S., Nedkova V., Koleva-Kolarova R. Copper in the human organism. Trakia J. Sci. 2011; 9, 88–98.

10. Wang K., Chen X., Cui Y., Gao X. The reference interval of zinc, copper, selenium and zinc/copper ratio of healthy adult in Licang. Trace Elem. Electroly. 2011; 28, 1–10.

11. Tapiero H., Townsend D. M., Tew K. D. Trace elements in human physiology and pathology. Copper. Biomed. Pharmacother. 2003; 57, 386–398.

12. Festa R. A., Thiele D. J. Copper: an Essential Metal in Biology. Curr. Biol. 2011; 21, R877–R883.

13. Ladomersky E., Petris M. J. Copper tolerance and virulence in bacteria Metallomics. 2015; 7, 957–964.

14. O’Gorman J., Humphreys H. Application of copper to prevent and control infection. Where are we now? J. Hosp. Infect. 2012; 81, 217–223.

15. Cai X., Zhang B., Liang Y., Zhang J., Yan Y., Chen X., Wu Z., Liu H., Wen S., Tan S., Wu T. Study on the antibacterial mechanism of copper ion- and neodymium ion-modified α-zirconium phosphate with better antibacterial activity and lower cytotoxicity. Colloid. Surface B. 2015; 132, 281–289.

16. Ren G., Hu D., Cheng E. W., Vargas-Reus M. A., Reip P., Allaker R. P. Characterisation of copper oxide nanoparticles for antimicrobial applications. Int. J. Antimicrob. Ag. 2009; 33, 587–590.

17. Borkow G., Gabbay J. Putting copper into action: copper impregnated products with potent biocidal activities. FASEB J. 2004; 18, 1728–1730.

18. Sagripanti J.-L., Routson L. B., Lytle C. D. Virus Inactivation by Copper or Iron Ions Alone and in the Presence of Peroxide. Appl. Environ. Microbiol. 1993; 59, 4374–4376.

19. Sagripanti J. L., Routson L. B., Bonifacino A. C., Lytle C. D. Mechanism of Copper-Mediated Inactivation of Herpes Simplex Virus. Antimicrob. Agents Ch. 1997; 41, 812–817.

20. Sagripanti J. L., Lightfoote M. M. Cupric and Ferric Ions Inactivate HIV. AIDS Res. Hum. Retrov. 1996; 12, 333–337.

21. Roblero L., Guadarrama A., Lopez T., Zegers-Hochschild F. Effect of copper ion on the motility, viability, acrosome reaction and fertilizing capacity of human spermatozoa in vitro. Reprod. Fertil. Dev. 1996; 8, 871–874.

22. Hostynek J. J., Maibach H. I. Copper hypersensitivity: dermatologic aspect – an overview. Rev. Environ. Health 2003; 18, 153–183.

23. Sivin I. Utility and drawbacks of continuous use of a copper T IUD for 20 years. Contraception 2007; 75, S70–S75.

24. Hubacher D., Lara-Ricalde R., Douglas M. D., Taylor J., Guerra-Infante F., Guzmán-Rodríguez R. Use of Copper Intrauterine Devices and the Risk of Tubal Infertility among Nulligravid Women. N. Engl. J. Med. 2001; 345, 561–567.

25. Stern B. R., Solioz M., Krewski D., Aggett P., Aw T.-Ch., Baker S., Crump K., Dourson M., Haber L., Hertzberg R., Keen C., Meek B., Rudenko L., Schoeny R., Slob W., Star T. Copper and Human Health: Biochemistry, Genetics, and Strategies for Modeling Dose-response Relationships. J. Toxicol. Environ. Health B Crit. Rev. 2007; 10, 157–222.

26. Mills C. F. Dietary interactions involving the trace elements. Annu. Rev. Nutr. 1985; 5, 173–193.

27. Sandstead H. H. Copper bioavailability and requirements. Am. J. Clin. Nutr. 1982; 35, 809–814.

28. Turnlund J. R., King J. C., Gong B., Keyes W. R., Michel M. C. A stable isotope study of copper absorption in young men: effect of phytate and α-cellulose. Am. J. Clin. Nutr. 1985; 42, 18–23.

29. Milne D. B., Klevay L. M., Hunt J. R. Effects of ascorbic acid supplements and a diet marginal in copper on indices of copper nutriture in women. Nutr. Res. 1988; 8, 865–873.

30. Jacob R. A., Skala J. H., Omaye S. T., Turnlund J. R. Effect of Varying Ascorbic Acid Intakes on Copper Absorption and Ceruloplasmin Levels in Young Men. J. Nutr. 1987; 117, 2109–2115.

31. Redman R. S., Fields M., Reiser S., Smith J. C. Jr. Dietary fructose exacerbates the cardiac abnormalities of copper deficiency in rats. Atherosclerosis 1988; 74, 203–214.

32. Holbrook J. T., Smith J. C. Jr., Reiser S. Dietary fructose or starch: effects on copper, zinc, iron, manganese, calcium and magnesium balances in humans. Am. J. Clin. Nutr. 1989; 49, 1290–1294.

33. World Health Organization Geneva. Trace elements in human nutrition and health. WHO Library Cataloguing in Publication Data 1996.

34. Lutsenko S. Human copper homeostasis: a network of interconnected pathways. Curr. Opin. Chem. Biol. 2010, 14, 211–217.

35. Collins J. F., Prohaska J. R., Knutson M. D. Metabolic crossroads of iron and copper. Nutr. Rev. 2010; 68, 133–147.

36. Nose Y., Wood L. K., Kim B.-U., Prohaska J. R., Fry R. S., Spears J. W., Thiele D. J. Ctr1 Is an Apical Copper Transporter in Mammalian Intestinal Epithelial Cells in Vivo That Is Controlled at the Level of Protein Stability. J. Biol. Chem. 2010; 285, 32385–32392.

37. Nose Y., Kim B.-E., Thiele D. J. Ctr1 drives intestinal copper absorption and is essential for growth, iron metabolism, and neonatal cardiac function. Cell Metab. 2006; 4, 235–244.

38. Kim H., Son H. Y., Bailey S. M., Lee J. Deletion of hepatic Ctr1 reveals its function in copper acquisition and compensatory mechanisms for copper homeostasis. Am. J. Physiol.-Gastr. L. 2009; 296, G356–G364.

39. Zimnicka A. M., Maryon E. B., Kaplan J. H. Human copper transporter hCTR1 mediates basolateral uptake of copper into enterocytes: implications for copper homeostasis. J. Biol. Chem. 2007; 282, 26471–26480.

40. Moriya M., Ho Y.H., Grana A., Nguyen L., Alvarez A., Jamil R., Ackland M.L., Michalczyk A., Hamer P, Ramos D., Kim S., Mercer J. F., Linder M. C. Copper is taken up efficiently from albumin and alpha2-macroglobulin by cultured human cells by more than one mechanism. Am. J. Physiol.-Cell Ph. 2008; 295, C708–C721.

41. Bost M., Houdart S., Oberli M., Kalonji E., Huneau J.-F., Margaritis I. Dietary copper and human health: Current evidence and unresolved issues. J. Trace Elem. Med. Bio. 2016; 35, 107–115.

42. Ferguson-Miller S., Babcock G. T. Heme/Copper Terminal Oxidases. Chem. Rev. 1996; 96, 2889–2908.

43. Wikstrom M. K. F. Proton pump coupled to cytochrome-c oxidase in mitochondria. Nature 1977; 266, 271–273.

44. Jepma M., Deinum J., Asplund Ch. L., Rombouts S. A., Tamsma J. T., Tjeerdema N., Spapé M. M., Garland E. M., Robertson D., Lenders J. W. M., Nieuwenhuis S. Neurocognitive Function in Dopamine-β-Hydroxylase Deficiency. Neuropsychopharmacol. 2011; 36, 1608–1619.

45. Biesemeier A., Kreppel F., Kochanek S., Schraermeyer U. The classical pathway of melanogenesis is not essential for melanin synthesis in the adult retinal pigment epithelium. Cell Tissue Res. 2010; 339, 551–560.

46. Saenko E. L., Yaropolov A. I., Harris E. D. Biological functions of ceruloplasmin expressed through copper-binding sites and a cellular receptor. J. Trace Elem. Exp. Med. 1994; 7, 69–88.

47. Mukhopadhyay Ch. K., Mazumder B., Fox P. L. Role of Hypoxia inducible Factor-1 in Transcription Activation of Ceruloplasmin by Iron Deficiency. J. Biol. Chem. 2000; 275, 21048–21054.

48. Bonham M., O’Connor J. M., Hannigan B. M., Strain J. J. The immune system as a physiological indicator of marginal copper status? Brit. J. Nutr. 2002; 87, 393–403.

49. Gaetke L. M., Chow Ch. K. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 2003, 189, 147–163.

50. Dizdaroglu M., Rao G., Halliwel B., Gajewski E. Damage to the DNA bases in mammalian chromatin by hydrogen peroxide in the presence of ferric and cupric ions. Arch. Biochem. Biophys. 1991; 285, 317–324.

51. Sagripanti J.-L., Kraemer K. H. Site-specific Oxidative DNA Damage at Polyguanosine Produced by Copper Plus Hydrogen Peroxide. J. Biol. Chem. 1989; 264, 1729–1734.

52. Sagripanti J.-L., Goering P. L., Lamanna A. Interaction of copper with DNA and antagonism by other metals. Toxicol. Appl. Pharm. 1991; 110, 477–485.

53. Li Y., Trush M. A. DNA damage resulting from the oxidation of hydroquinone by copper: role for a Cu(II)Cu(I) redox cycle and reactive oxygen generation. Carcinogenesis. 1993; 14, 1303–1311.

54. Toyokosni S., Sagripanti J.-L. Increased 8-hydroxyguanosine in kidney and liver of rats continuously exposed to copper. Toxicol. Appl. Pharm. 1994; 126, 91–97.

55. Samuni A., Aronovitch J., Godinger D., Chevion M., Czapski G. On the cytotoxicity of vitamin C and metal ions. A site-specific Fenton mechanism. Eur. J. Biochem. 1993; 137, 119–124.

56. Stohs S. J., Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radical Bio. Med. 1995; 18, 321–336.

57. Birben E., Sahiner U. M., Sackesen C., Erzurum S., Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J. 2012; 5, 9–19.

58. Wang X., Moulla D., Wright J.A., Brown D. R. Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity. J. Neurochem. 2010; 113, 704–714.

59. Iakovidis I., Delimaris I., Piperakis S. M. Copper and Its Complexes in Medicine: A Biochemical Approach. SAGE-Hindawi Access to Research. Mol. Biol. Int. 2011; Article ID 594529, 13p.

60. Muñoz C., López M., Olivares M., Pizarro F., Arredondo M., Araya M. Differential response of interleukin-2 production to chronic copper supplementation in healthy humans. Eur. Cytokine Netw. 2005; 16, 261–265.

61. Uriu-Adams J. Y., Keen C. L. Copper, oxidative stress, and human health. Mol. Aspects Med. 2005; 26, 268–298.

62. Hawk S. N., Lanoue L., Keen C. L., Kwik-Uribe C. L., Rucker R. B., Uriu-Adams J. Y. Copper-deficient rat embryos are characterized by low superoxide dismutase activity and elevated superoxide anions. Biol. Reprod. 2003; 68, 896–903.

63. Lynch S. M., Frei B., Morrow J. D., Roberts L. J., Xu A., Jackson T., Reyna R., Klevay L. M., Vita J. A., Keaney J. F. Jr. Vascular superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. Arterioscl. Throm. Vas. 1997; 17, 2975–2981.

64. Johnson W. T., Thomas A. C. Copper deprivation potentiates oxidative stress in HL-60 cell mitochondria. Proc. Soc. Exp. Biol. Med. 1999; 221, 147–152.

65. Chen Y., Saari J. T., Kang Y. J. Weak antioxidant defenses make the heart a target for damage in copper-deficient rats. Free Radical Bio. Med. 1994; 17, 529–536.

66. Nelson S. K., Huang C. J., Mathias M. M., Allen K. G. Copper-marginal and copper-deficient diets decrease aortic prostacyclin production and copper-dependent superoxide dismutase activity, and increase aortic lipid peroxidation in rats. J. Nutr. 1992; 122, 2101–2108.

67. Brewer G. J. Copper Control as an Antiangiogenic Anticancer Therapy: Lessons from Treating Wilson’s Disease. Exp. Biol. M. 2001; 226, 665–673.

68. Xu L., Pu J. Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application. Hindawi Publishing Corporation Parkinson’s Disease. 2016; Article ID 1720621, 10p.

69. Gupte A., Mumper R. J. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat. Rev. 2009; 35, 32–46.

70. Zowczak M., Iskra M., Paszkowski J., Mańcyak M., Torliński L., Wysocka E. Oxidase activity of ceruloplasmin and concentrations of copper and zinc in serum of cancer patients. J. Trace Elem. Med. Bio. 2001; 15, 193–196.

71. Samanovic M. I., Ding C., Thiele D. J., Darwin K. H. Copper in microbial pathogenesis: meddling with the metal. Cell Host Microbe 2012; 11, 106–115.

72. Warnes S. L., Caves V., Keevil C. W. Mechanism of copper surface toxicity in Escherichia coli 0157:H7 and Salmonella involves immediate membrane depolarization followed by slower rate of DNA destruction which differs from that observed for Gram-positive bacteria. Environ. Microbiol. 2012; 14, 1730–1743.

73. Santo C. E., Lam E. W., Elowsky C. G., Quaranta D., Domaille D. W., Chang C. J., Grass G. Bacterial Killing by Dry Metallic Copper Surfaces. Appl. Environ. Microb. 2011; 77, 794–802.

74. Borkow G., Gabbay J. Copper, An Ancient Remedy Returning to Fight Microbial, Fungal and Viral Infections. Curr. Chem. Bio. 2009; 3, 272–278.

75. Grass G., Rensing C., Solioz M. Metallic Copper as an Antimicrobial Surface. Appl. Environ. Microb. 2011; 77, 1541–1547.

76. Macomber L., Imlay J. A. The iron-sulfur clusters of dehydratases are primary intracellular targets of copper toxicity. P. Natl. Acad. Sci. USA. 2009; 106, 8344–8349.

77. Sagripanti J.-L. Metal-based formulations with high microbicidal activity. Appl. Environ. Microb. 1992; 58, 3157–3162.

78. Borkow G., Sidwell R. W., Smee D. F., Barnard D. L., Morrey J. D., Lara-Villegas H. H. , Shemer-Avni Y., Gabbay J. Neutralizing Viruses in Suspensions by Copper Oxide-Based Filters. Antimicrob. Agents Ch. 2007; 51: 2605–2607.

79. Borkow G., Lara H. H., Covington C. Y., Nyamathi A., Gabbay J. Deactivation of human immunodeficiency virus type 1 in medium by copper oxide-containing filters. Antimicrob. Agents Ch. 2008; 52, 518–525.

80. Abad F. X., Pinto R. M., Diez J. M., Bosch A. Disinfection of human enteric viruses in water by copper and silver in combination with low levels of chlorine. Appl. Environ. Microb. 1994, 60, 2377–2383.

81. Samuni A., Chevion M., Czapski G. Roles of copper and superoxide anion radicals in the radiation-induced inactivation of T7 bacteriophage. Radiat. Res. 1984; 99, 562–572.

82. Borkow G., Okon-Levy N., Gabbay J. Copper oxide impregnated wound dressings: biocidal and safety studies. Wounds 2010; 22, 301–310.

83. Sen C. K., Khanna S., Venojarvi M., Trikha P., Ellison E. C., Hunt T. K., Roy S. Copper-induced vascular endothelial growth factor expression and wound healing. Am. J. Physiol.-Heart C. 2002; 282, H1821–H1827.

84. Thneibat A., Fontana M, Cochran M. A., Gonzalez-Cabezas C., Moore B. K., Matis B. A., Lund M. R. Anticariogenic and antibacterial properties of a copper varnish using an in vitro microbial caries model. Oper. Dent. 2008; 33, 142–148.

85. Foley J., Blackwell A. In vivo cariostatic effect of black copper cement on carious dentine. Caries Res. 2003; 37, 254–260.

86. Wu J. P., Pickle S. Extended use of the intrauterine device: a literature review and recommendations for clinical practice. Contraception 2014; 89, 495–503.

87. Bilian X. Intrauterine devices. Best Pract. Res. Cl. Ob. 2002; 16, 155–168.

88. Stérimar. https://sterimar.com/en/our-products/nez-sujet-aux-infections/ (26. 4. 2018)

89. Pavelková M., Kubová K., Vysloužil J., Kejdušová M., Vetchý D., Celer V., Molinková D., Lobová D., Pechová A., Vysloužil J., Kulich P. Biological effects of drug-free alginate beads cross-linked by copper ions prepared using external ionotropic gelation. AAPS Pharmscitech. 2017; 18, 1343–1354.

90. Jackson G. E., May P. M., Williams D. R. Metal-ligand complexes involved in rheumatoid arthritis-I: justifications for copper administration. J. Inorg. Nucl. Chem. 1978; 40, 1189–1194.

91. El-Gammal O. A., Elmorsy E. A., Sherif Y. E. Evaluation of the anti-inflammatory and analgesic effects of Cu(II) and Zn(II) complexes derived from 2-(naphthalen-1-yloxy)-N‘-(1-(pyridin-2-1)ethylidene)acetohydrazide. Spectrochim. Acta A. 2014; 120, 332–339.

92. Tisato F., Marzano C., Porchia M., Pellei M., Santini C. Copper in diseases and treatments, and copper-based anticancer strategies. Med. Res. Rev. 2010; 30, 708–749.

93. Weaver L., Michels H. T., Keevil C. W. Survival of Clostridium difficile on copper and steel: futuristic options for hospital hygiene. J. Hosp. Infect. 2008; 68, 145–151.

94. Mehtar S., Wiid I., Todorov S. D. The antimicrobial activity of copper and copper alloys against nosocomial pathogens and Mycobacterium tuberculosis isolated from healthcare facilities in the Western Cape: an in vitro study. J. Hosp. Infect. 2008; 68, 45–51.

95. Noyce J. O., Michels H., Keevil C. W. Potential use of copper surfaces to reduce survival of epidemic meticillin-resistant Staphylococcus aureus in the healthcare environment. J. Hosp. Infect. 2006; 63, 289–297.

96. Noyce J. O., Michels H., Keevil C. W. Inactivation of influenza A virus on copper versus stainless steel surfaces. Appl. Environ. Microbiol. 2007; 73, 2748–2750.

97. Borkow G., Gabbay J. Biocidal textiles can help fight nosocomial infections. Med. Hypotheses 2008; 70, 990–994.

98. Gabbay J., Borkow G., Mishal J., Magen E., Zatcoff R., Shemer-Avni Y. Copper oxide impregnated textiles with potent biocidal activities. J. Ind. Text. 2006; 35, 323–335.

99. Mumcuoglu K. Y., Gabbay J., Borkow G. Copper oxide-impregnated fabrics for the control of house dust mites. Int. J. Pest Manage. 2008; 54, 235–240.

100. Zatcoff R. C., Smith M. S., Borkow G. Treatment of tinea pedis with socks containing copper-oxide impregnated fibers. Foot. 2008; 18, 136–141.

101. Lin Y. E., Vidic R. D., Stout J. E., Yu V. L. Legionella in water distribution systems. J. AWWA. 1998; 90, 112–121.

102. Rohr U., Weber S., Selenka F., Wilhelm M. Impact of silver and copper on the survival of amoebae and ciliated protozoa in vitro. Int. J. Hyg. Envir. Heal. 2000; 203, 87–89.

103. Cachafeiro S. P., Naveira I. M., García I. G. Is copper-silver ionisation safe and effective in controlling legionella? J. Hosp. Infect. 2007; 67, 209–216.

104. Gorter R. W., Butorac M., Cobian E. P. Examination of the cutaneous absorption of copper after the use of copper-containing ointments. Am. J. Ther. 2004; 11, 453–458.

105. Mulligan A. M., Wilson M., Knowles J. C. The effect of increasing copper content in phosphate-based glasses on biofilms of Streptococcus sanguis. Biomaterials 2003; 24, 1797–1807.

106. Faúndez G., Troncoso M., Navarrete P., Figueroa G. Antimicrobial activity of copper surfaces against suspensions of Salmonella enterica and Campylobacter jejuni. BMC Microbiol. 2004; 4, 7p.

107. Hassan A. A., Shoukary N. M., Ismail N. M. Efficacy of temperature, and two commonly used molluscicides and fertilizers on Fasciola gigantica eggs. J. Egypt. Soc. Parasitol. 2008; 38, 621–634.

108. Borkow G., Zhou S. S., Page T., Gabbay J. A novel anti-influenza copper oxide containing respiratory face mask. PLoS ONE. www.plosone.org. 2010; 5, e11295.

109. La Torre A., Talocci S., Spera G., Valori R. Control of downy mildew on grapes in organic viticulture. Commun. Agric. Appl. Biol. Sci. 2008; 73, 169–178.

110. Schultz T. P., Nicholas D. D., Preston A. F. A brief review of the past, present and the future of wood preservation. Pest. Manag. Sci. 2007; 63, 784–788.

111. Ragab F., Shoukry N.M. Influence of certain fertilizers on the activity of some molluscicides against Biomphalaria alexandrina and Lymnaea natalensis snails. J. Egypt. Soc. Parasitol. 2006; 36, 959–977.

112. UK Marine Special Areas of Conservation. Copper-based antifouling paints. www.ukmarinesac.org.uk/activities/ports/ph4_3_1.htm (27. . 018).

113. Cooney T. E. Bactericidal activity of copper and noncopper paints. Infect. Cont. Hosp. Ep. 1995; 16, 444–450.

114. Cooney J. J., Tang R. J. Quantifying effects of antifouling paints on microbial biofilm formation. Method. Enzymol. 1999; 310, 637–644.